ENDOSCOPIC ENDONASAL TRANS-SPHENOIDAL SURGERY IN PATIENTS WITH MACRO-ADENOMA EXTENT OF SURGICAL RESECTION AND RECURRENCE RATE

Authors

  • Zia Ur Rahman Drpartment of Neurosurgery Lady Reading Hospital Peshawar-Pakistan
  • Muhammad Idris Khan Department of Neurosurgery Khyber Teaching Hospital Peshawar-Pakistan
  • Muhammad Aamir Drpartment of Neurosurgery Lady Reading Hospital Peshawar-Pakistan

Keywords:

Macro-adenomas, Endoscopic Endonasal Trans-sphenoidal Approach

Abstract

Background: EETA has been employed for skull base tumors especially macro—adenomas, for the last decade in our setup. Here we are sharing our experience with the EETA for patients with micro-adenomas in terms of extent of tumor resection and its recurrence. The objective was to assess endoscopic endonasal trans-sphenoidal surgery in patients with macro-adenoma for extent of surgical resection and recurrence rate. Methods: This descriptive case series study was carried out from May 2021 till April 2023. Male and female patients with macroadenoma were enrolled which was diagnosed with contrast enhanced volumetric MRI brain. EETA and resection was performed. Extent of resection recurrence was confirmed on post-op MRI and follow up at 6 months respectively. Results: A total of 58 patients were enrolled. Mean age of the patients was 47.51 ± 7.93 years and male to female ratio was 1.3: 1. 42 (72.4%) tumors were non-functional. Somatotropin releasing tumor was the most common functional tumor (n = 09, 15.5%). Total resection was performed in 49 (84.4%) patients. Recurrence was observed in 09 (15.6%) cases. Conclusion: EETA has been shown to be a safe and effective technique for the resection of macroadenoma of the skull base.

References

Asemota AO, Ishii M, Brem H, Gallia GL. Comparison of Complications, Trends, and Costs in Endoscopic vs Microscopic Pituitary Surgery: Analysis From a US Health Claims Database. Clin Neurosurg (2017) 81(3):458–71.

Molitch ME. Diagnosis and Treatment of Pituitary Adenomas: A Review. JAMA - J Am Med Assoc (2017) 317:516–24.

Melmed S. Mechanisms for Pituitary Tumorigenesis: The Plastic Pituitary. J Clin Invest (2003) 112:1603–18.

Melmed S. Pituitary-Tumor Endocrinopathies. Longo DL, Editor. N Engl J Med (2020) 382(10):937–50.

Suri H, Dougherty C. Clinical Presentation and Management of Headache in Pituitary Tumors. Curr Pain Headache Rep (2018) 22:1–6.

Kim SH, Lee KC, Kim SH. Cranial Nerve Palsies Accompanying Pituitary Tumour. J Clin Neurosci (2007) 14(12):1158–62.

Vernooij MW, Ikram MA, Tanghe HL, Vincent AJPE, Hofman A, Krestin GP, et al.. Incidental Findings on Brain MRI in the General Population. N Engl J Med (2007) 357(18):1821–8.

Barkhoudarian G, Palejwala SK, Ansari S, Eisenberg AA, Huang X, Griffiths CF, et al.. Rathke’s Cleft Cysts: A 6-Year Experience of Surgery vs. Observation With Comparative Volumetric Analysis. Pituitary (2019) 22(4):362–71.

Larkin S, Karavitaki N, Ansorge O. Rathke’s Cleft Cyst. In: Handbook of Clinical Neurology. Amsterdam: Elsevier B.V; (2014). p. 255–69.

Müller HL. Craniopharyngioma. Endocr Rev (2014) 35:513–43.

O’Steen L, Indelicato DJ. Advances in the Management of Craniopharyngioma [Version 1; Peer Review: 3 Approved]. F1000 Res (2018) 7.

Goffart Y, Jorissen M, Daele J, Vander Poorten V, Born J, Deneufbourg JM, et al.. Minimally Invasive Endoscopic Management of Malignant Sinonasal Tumours. Acta Otorhinolaryngol Belg (2000) 54(2):221–32.

Bogaerts S, Vander Poorten V, Nuyts S, Van Den Bogaert W, Jorisser M. Results of Endoscopic Resection Followed by Radiotherapy for Primarily Diagnosed Adenocarcinomas of the Paranasal Sinuses. Head Neck (2008) 30(6):728–36.

Van Gerven L, Jorissen M, Nuyts S, Hermans R, Vander Poorten V. Long-Term Follow-Up of 44 Patients With Adenocarcinoma of the Nasal Cavity and Sinuses Primarily Treated With Endoscopic Resection Followed by Radiotherapy. Head Neck (2011) 33(6)898–904.

Published

2024-06-21